openPR Logo
Press release

Human Milk Oligosaccharides (HMO) Market is growing at a CAGR of 14.1% by 2028

08-19-2021 08:56 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Human Milk Oligosaccharides (HMO) Market

Human Milk Oligosaccharides (HMO) Market

According to a new report published by Allied Market Research, titled, “Human Milk Oligosaccharides (HMOs) Market by Type, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021–2028,”the global human milk oligosaccharides (HMO) market size was valued at $125.9 million in 2020, and is estimated to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028.

Human milk oligosaccharide (HMO) is a prebiotic that aids in the maintenance of human gut health. It stimulates bacterial growth, particularly in the Bifidobacteriagenus, which aids in metabolic activity. Owing to its antimicrobial and prebiotic properties, it can be used in a variety of foods, including pharmaceutical and medicinal foods as well as infant formulas.

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/12392

HMOs are sugars, which are the third most abundant solid nutrients in human breast milk after lactose and fats. They improve and enhance infant health by promoting immune development, neurodevelopment, and digestion, and also have the potential to benefit adults. Some of the nutritional effects of HMOs found in human milk can be recreated by commercially manufactured HMOs.

Fermented HMO allows infant formula manufacturers to produce formula that is more similar to human milk than ever before, allowing formula-fed babies to benefit from these important components of breast milk. Human milk oligosaccharides serve a variety of primary functions, including infection prevention, prebiotic effects, and sialic acid supply for brain growth. Infant formula made from bovine milk, that is cow milk, contains less oligosaccharides than human milk. Ash MOs are beneficial to the micro biome and immunity, key players are researching and developing new techniques, such as extracting HMO from cow milk using expensive techniques, or even generating them using microbes.

The rapid evolution of consumer preferences is one of the key factors driving innovation in the food & beverage industry. At present, the current Human Milk Oligosaccharides (HMO) market trends indicate that the demand for HMOs is expected to grow at a significant rate in the coming years, due to the steady rise in number of health-conscious people around the world as well as increase in awareness about the benefits of HMOs. Owing to rise in customer concerns about stable health and increase in the use of food supplements or dietary supplements, the Human Milk Oligosaccharides (HMO) market has witnessed exponential growth.

Get detailed COVID-19 impact analysis on the Human Milk Oligosaccharides (hmo) Market @ https://www.alliedmarketresearch.com/request-for-customization/12392?reqfor=covid

Furthermore, over the last decade, a large number of players have gradually entered the global Human Milk Oligosaccharides (HMO) market, resulting in the availability of HMOs with a wide range of nutritional content through a variety of distribution channels. Another factor that has contributed to the popularity of HMOs in recent years is the digital boom, which has seen brands continue to promote their products via online sales channels such as e-mail marketing, social media, and newsletters. While the global Human Milk Oligosaccharides (HMO) market remains competitive, market participants are expected to concentrate on packaging, pricing, and marketing strategies to gain a competitive advantage in the current market landscape.

The Human Milk Oligosaccharides (HMO) market segmentation is done on the basis of type, application, distribution channel, and region. By type, the market is categorized into2’FL, 3’FL, 3’SL, and 6’SL. The applications covered in the study include infant formula, functional food & beverage, and food supplements. According to distribution channel, the Human Milk Oligosaccharides (HMO )market is fragmented into hypermarkets & supermarkets, drug store or pharmacy, mass merchandiser, departmental stores, mono-brand stores, specialty stores, and online sales channel. Regionwise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In this way, Human Milk Oligosaccharides (HMO) market analysis is done.

By type, the 2’FLsegment was the highest revenue contributor in 2020,due to the fact that the ability of 2’FL is to protect against infectious diseases by preventing toxins and pathogens from adhering to epithelial cells is well noticeable. Depending on application, the infant formula segment held the largest Human Milk Oligosaccharides (HMO) market share, as HMOs’ beneficial properties such as memory formation and cognitive performance help in the growth and development of infants. As per distribution channel, the drug stores or pharmacy segment led the Human Milk Oligosaccharides (HMO) market. This is attributed to the fact that to drug store operators have emphasized convenience factors such as extended store hours and drive-through locations to attract and retain customers during increasing competition from mail-order retailers and supercenters.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/12392

Owing to global concerns about poor nutrition and premature death, the demand for HMO in infant formula is accelerating market growth. This is attributed to the fact that HMOsexhibit prebiotic properties, the potential to improve memory & brain growth, and a high nutritional value. This is also one of the Human Milk Oligosaccharides (HMO) market opportunity. The ability of breast milk to protect babies from infection and allergic reactions is expected to positively impact the market size, as human milk appears to provide long-term protection against obesity, hypertension, inflammation, diabetes, and heart disease in humans.

The introduction of new products is expected to reduce the impact of specific diseases such as diabetes and indigestion. Some major manufacturers have already started to offer products in specific health and wellness categories, such as digestion and cognitive enhancement. This trend is expected to take center stage and gain significant traction in the rapidly expanding functional food & beverage market, as well as significant brand equity, during the Human Milk Oligosaccharides (HMO) market forecast.

The third most abundant component of human milk is human oligosaccharides, which cannot be synthesized directly from human milk due to the donor group’s scarcity. Currently, manufacturers use chemical and enzyme synthesis to produce human milk oligosaccharides. These methods necessitate a large investment of time and money, but the end result is relatively small.

Request for Customization: https://www.alliedmarketresearch.com/request-for-customization/12392

For example, expensive substrates such as glycosyl-transferases necessitate enzyme synthesis, which is one of the primary reasons for the high price of human milk oligosaccharides. Prebiotics, such as fructooligosaccharides and galactooligosaccharides, are used in infant formula to prevent the growth of pathogenic Escherichia coli bacteria. Consumption of these has been shown to improve infant gastrointestinal tract health by promoting the development of specific microorganisms in the intestinal micro flora. Infant formula manufacturers use these as a substitute for HMOs due to their low cost and widespread availability. As a result, these functionally equivalent alternatives to HMOs are severely limiting market growth.

In 2020, the outbreak of the COVID-19 pandemic had an impact on the global Human Milk Oligosaccharides (HMO) market growth. Retail stores, malls, supermarkets, and other sales channels have been closed as a result of stringent lockdown imposed by governments around the world. During the lockdown, however, several brands have shifted their focus to e-commerce platforms to generate revenue and increase sales. Offline sales are increasing currently, as government lockdown restrictions are gradually being lifted in a number of countries.

Product launches, mergers & acquisitions, joint ventures, and geographical expansions are the key strategies adopted by players in the Human Milk Oligosaccharides (HMO) industry. The key players operating in the Human Milk Oligosaccharides (HMO) industry include Abbott Laboratories, BASF S.E., Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, and ZuChem.

Key findings of the study

The global Human Milk Oligosaccharides (HMO) market was valued at $125.9 million in 2020, and is projected to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028.
Europe was the highest revenue contributor, accounting for $45.3 million in 2020, and is estimated to reach $124.1 million by 2028, with a CAGR of 14.6%.
By type, the 2’FL segment was the highest contributor to the market, with $42.3 million in 2020, and is estimated to reach $120.6 million by 2028, at a CAGR of 14.6% during the forecast period.
On the basis of application, the infant formula segment was the highest contributor to the market, with $67.9 million in 2020, and is estimated to reach $191.7 million by 2028, at a CAGR of 14.5% during the forecast period.
In Europe, the UK was the highest revenue contributor with $12.5 million in 2020, and is estimated to reach $37.5 Million by 2028, registering a CAGR of 15.4%.

Access Full Summary: https://www.alliedmarketresearch.com/human-milk-oligosaccharides-hmo-market-A12027

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada): +1-800-792-5285, +1-503-446-1141
International: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research/

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Milk Oligosaccharides (HMO) Market is growing at a CAGR of 14.1% by 2028 here

News-ID: 2359956 • Views: 297

More Releases from Allied Market Research

Fantasy Sports Market in Asia-Pacific & Canada is Expected to Reach $3,739.8 Mil …
According to a new report published by Allied Market Research, titled, “Asia-Pacific & Canada Fantasy Sports Market by Sports Type, Platform, and Demographic: Regional Opportunity Analysis and Industry Forecast, 2021–2027,” Asia-Pacific & Canada fantasy sports market size was valued at $2,021.9 million in 2019, and is projected to reach $3,739.8 million by 2027, growing at a CAGR of 10.7% from 2021 to 2027. Fantasy sport is played using internet where participants
Hammock Market Size Is Projected Reach $639.8 Million By 2030, Registering At A …
Surge in hiking and adventure tourism, rise in demand from residential segment, and expansion of hospitality industry drive the growth of the global hammock market. North America contributed to the highest share in terms of revenue in 2020. The outbreak of the COVID-19 pandemic has resulted in transition of consumers toward online sales channels to purchase campaigning gear products including hammocks. According to the report published by Allied Market Research, the
Cotton Personal-Care Product Market 2021: Top Factors That Are Leading The Deman …
A lead analyst at AMR highlighted the market across Europe region is expected to dominate in terms of revenues throughout the forecast period. Allied Market Research published a research report on the Cotton personal-care product market. The findings of the report states that the global market for Cotton personal-care product is expected to reach $19.15 billion by 2028, manifesting a CAGR of 4.6% from 2020 to 2028. The report provides valuable
Global Football Sportswear Market Growing Trade Among Emerging Economies Opening …
As per the report published by Allied Market Research, the global football sportswear market is estimated to reach $114.41 billion by 2027, growing at a CAGR of 5.3% from 2021 to 2027. The report highlights market characteristics, market potential, and growth by segmentation, and competitive landscape. Rise in sportswomen, surge in participation in football, and development in sportswear drive the growth of the global football sportswear market. Access Full Summary: https://www.alliedmarketresearch.com/football-sportswear-market-A09835 Chinese companies

All 5 Releases


More Releases for HMO

Live Launch of JumboTiger (Coliving, HMO and Property Management Software)
JumboTiger is a full-stack real-time conversational property management software. It helps landlords/ owners, property managers, coliving & HMO operators to manage their rental portfolio. Lunch on - 16th Feb, 2021, 04:00PM GMT Register link for launch - https://zoom.us/webinar/register/WN_4B8oQpelR-KXFn17HdIyog What made you start your startup and what problem does it solve? We were running a successful bootstrapped coliving startup called [simplyguest.com] since 2015. We were growing at 10-15% m-o-m and had built a pretty successful business.
Human Milk Oligosaccharides (HMO) Global Market 2018: Key Players – Abbott, In …
Human Milk Oligosaccharides (HMO) Industry Description Wiseguyreports.Com Adds “Human Milk Oligosaccharides (HMO) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database This report studies the global market size of Human Milk Oligosaccharides (HMO) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Milk Oligosaccharides (HMO) in these regions.  This research report
Human Milk Oligosaccharides (HMO) Market Share by Manufacturers, Revenue Status …
Global Human Milk Oligosaccharides (HMO) Market report explores and analyses the essential factors of market depending on present industry situations, market needs, business strategies and the growth condition. This report provides in depth study of “Human Milk Oligosaccharides (HMO) market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Human Milk Oligosaccharides (HMO) Market report also provides an in-depth survey of key players in the market which
Human Milk Oligosaccharides (HMO) Market Research Report 2017
Reports And Markets Publish a New Market Research Report On –"Human Milk Oligosaccharides (HMO) Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-human-milk-oligosaccharides-hmo-market-research-report-2017-1541215 In this report, the global Human Milk Oligosaccharides (HMO) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented
Global Human Milk Oligosaccharides (HMO) Market Research Report 2016
This report studies Human Milk Oligosaccharides (HMO) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Beghin Meiji (France) Beneo-Orafti SA (Belgium) Cargill, Inc. (US) Cosucra Groupe Warcoing SA (Belgium) Ingredion Incorporated (US) Royal Cosun (The Netherlands) Sensus (The Netherlands) Yakult Pharmaceutical Industry Co., Ltd. (Japan) Major Manufacturers of Prebiotic Food Products Abbott Nutrition (US) Clasado BioSciences
Human Milk Oligosaccharides (HMO) Market - Global Industry Analysis 2024
Human Milk Oligosaccharides (HMO) is a complex bioactive sugar molecule present in human milk. It functions as growth substrates for particular beneficial bacteria. Due to being structurally complex and diverse, extracting or synthesizing them for use in the formula is challenging. As human milk oligosaccharides (HMO) is beneficial for microbiome and immunity, therefore, many new techniques are getting researched and developed by the key player which include extracting HMO from